Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Employees in Februar work in a lab at Emergent Biosolutions, which has been manufacturing COVID-19 vaccines for AstraZeneca and Johnson & Johnson in Baltimore, Maryland. Photo: Michael Robinson Chavez/The Washington Post via Getty Images

Johnson & Johnson announced late Saturday that it's "assuming full responsibility" for manufacturing its COVID-19 vaccine at a Baltimore plant where 15 million doses were ruined last week.

Of note: AstraZeneca said Saturday night it is in "full cooperation with the U.S. government" moving production from the facility, run by Emergent BioSolutions, which been producing both vaccines.

Why it matters: The Biden administration took the "extraordinary" step of intervening as officials were "worried" the error would "erode public confidence in the vaccines," notes the New York Times, which first reported the news Saturday.

Driving the news: Both Bloomberg and Reuters report that the Department of Health and Human Services "facilitated" the move.

  • J&J said in a statement that it's "adding dedicated leaders for operations and quality, and significantly increasing the number of manufacturing, quality and technical operations personnel to work with the company specialists already at Emergent."
  • AstraZeneca, which has yet to receive FDA approval, said in a statement Saturday night it "will work with the U.S. Government to identify an alternative location."

For the record: The plant has yet to receive authorization from the Food and Drug Administration for either vaccine and the error is unlikely to impact the U.S. government's acceleration of the vaccine rollout.

  • President Biden is stepping up plans to enable every American adult to have access to a dose by May, but the mix-up underscores how manufacturing issues "could complicate the rollout," per Bloomberg.

What to watch: J&J said in its statement it "expects to deliver nearly 100 million single-shot doses of its COVID-19 vaccine to the U.S. Government by the end of May."

What they're saying: Emergent spokesperson Nina DeLorenzo told the Washington Post Saturday that the company had been told of AstraZeneca's relocation plans and would stop manufacturing the vaccine in "the next few days."

  • "We are welcoming additional Johnson & Johnson personnel on-site at Bayview for their technical expertise and support," DeLorenzo added.
  • Representatives for Emergent and the Department of Health and Human Services did not immediately respond to Axios' request for comment.

Go deeper

Apr 4, 2021 - World

Argentina's president tests positive for COVID after vaccination

President Alberto Fernández during the opening session of the 139th period of the Argentine Congress on March 1 in Buenos Aires, Argentina. Photo: Natacha Pisarenko - Pool/Getty Images

Argentina's President Alberto Fernández announced Saturday that he's tested positive for COVID-19.

Of note: Fernández received his first dose of Russia’s Sputnik V coronavirus vaccine on Jan. 21 and the second on Feb. 11, per the Wall Street Journal.

Super typhoon Surigae explodes to Cat. 5 intensity

Super Typhoon Surigae seen on satellite imagery Saturday morning east of the Philippines. (CIRA/RAMMB)

Super Typhoon Surigae surged in intensity from a Category 1 storm on Friday to a beastly Category 5 monster on Saturday, with maximum sustained winds estimated at 190 mph with higher gusts.

Why it matters: This storm — known as Typhoon Bising in the Philippines — is just the latest of many tropical cyclones to undergo a process known as rapid intensification, a feat that studies show is becoming more common due to climate change. It weakened slightly, to the equivalent of a strong Category 4 storm, on Sunday.

3 hours ago - World

Biden adviser warns "there will be consequences" for Russia if Navalny dies

The Biden administration warned the Russian government "that there will be consequences" if jailed Russian opposition leader Alexei Navalny dies, National Security Adviser Jake Sullivan told CNN on Sunday.

The big picture: Sullivan also defended President Biden for not mentioning Navalny in a Thursday speech about Russia or in a Tuesday call with Russian President Vladimir Putin, saying the White House aims to deal with the issue "privately and through diplomatic channels."